The average one-year price target for Strides Pharma Science (NSEI:STAR) has been revised to ₹ 1,244.40 / share. This is a decrease of 19.21% from the prior estimate of ₹ 1,540.20 dated September 27, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of ₹ 1,232.20 to a high of ₹ 1,281.00 / share. The average price target represents an increase of 52.96% from the latest reported closing price of ₹ 813.55 / share.
Strides Pharma Science Maintains 0.49% Dividend Yield
At the most recent price, the company’s dividend yield is 0.49%.
Additionally, the company’s dividend payout ratio is 0.11. The payout ratio tells us how much of a company’s income is paid out in dividends. A payout ratio of one (1.0) means 100% of the company’s income is paid in a dividend. A payout ratio greater than one means the company is dipping into savings in order to maintain its dividend - not a healthy situation. Companies with few growth prospects are expected to pay out most of their income in dividends, which typically means a payout ratio between 0.5 and 1.0. Companies with good growth prospects are expected to retain some earnings in order to invest in those growth prospects, which translates to a payout ratio of zero to 0.5.
What is the Fund Sentiment?
There are 53 funds or institutions reporting positions in Strides Pharma Science. This is an increase of 6 owner(s) or 12.77% in the last quarter. Average portfolio weight of all funds dedicated to STAR is 0.06%, an increase of 87.88%. Total shares owned by institutions increased in the last three months by 4.20% to 5,640K shares.
What are Other Shareholders Doing?
VGTSX - Vanguard Total International Stock Index Fund Investor Shares holds 910K shares representing 0.99% ownership of the company. In its prior filing, the firm reported owning 949K shares , representing a decrease of 4.29%. The firm increased its portfolio allocation in STAR by 14.83% over the last quarter.
IEMG - iShares Core MSCI Emerging Markets ETF holds 843K shares representing 0.91% ownership of the company. In its prior filing, the firm reported owning 832K shares , representing an increase of 1.28%. The firm increased its portfolio allocation in STAR by 25.51% over the last quarter.
VEIEX - Vanguard Emerging Markets Stock Index Fund Investor Shares holds 824K shares representing 0.89% ownership of the company. In its prior filing, the firm reported owning 779K shares , representing an increase of 5.53%. The firm increased its portfolio allocation in STAR by 20.76% over the last quarter.
DFCEX - Emerging Markets Core Equity Portfolio - Institutional Class holds 422K shares representing 0.46% ownership of the company. No change in the last quarter.
Dimensional Emerging Markets Value Fund - Dimensional Emerging Markets Value Fund holds 329K shares representing 0.36% ownership of the company. No change in the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
